Gilead Sciences Inc. (GIS)
XETR
Closed
Aug 24, 2026
Day's Range
124.1252 wk Range
92.41Overview - GIS - Gilead Sciences Inc.
Key Statistics
Valuation
Enterprise Value
151.87B
P/E (Trailing)
‪17.68‬
PEG Ratio
‪-0.02‬
Price / Sales (TTM)
‪5.13‬
Price / Book
‪15.32‬
EV / EBITDA
‪12.17‬
Profitability
Gross Margin
‪79.76%‬
Profit Margin
‪-10.63%‬
Operating Margin
‪33.67%‬
Return on Assets
‪14.08%‬
Return on Equity
‪-20.68%‬
Ownership
Shares Outstanding
1.24B
Float
1.23B
Held by Insiders
‪0.11%‬
Held by Institutions
‪92.27%‬
Price stats
Beta
‪0.33‬
50-Day Avg
‪114.45‬
200-Day Avg
‪114.67‬
Dividends
Payout Ratio
‪43.40%‬
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - GIS - Gilead Sciences Inc.
Peers - GIS - Gilead Sciences Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on XETR.
- GISXETRGilead Sciences Inc.156.60BMarket Cap+21.83%52-week change17.69P/E (Trailing)‪-10.63%‬Profit Margin
- LLYXETREli Lilly and Company967.83BMarket Cap+44.68%52-week change42.40P/E (Trailing)‪33.52%‬Profit Margin
- JNJXETRJohnson & Johnson560.78BMarket Cap+34.27%52-week change31.45P/E (Trailing)‪21.48%‬Profit Margin
- 4ABXETRAbbVie Inc.403.07BMarket Cap+21.79%52-week change74.52P/E (Trailing)‪9.80%‬Profit Margin
- 6MKXETRMerck & Co., Inc.324.08BMarket Cap+44.20%52-week change120.52P/E (Trailing)‪4.76%‬Profit Margin
- RHOXETRRoche Holding AG323.64BMarket Cap+28.61%52-week change24.90P/E (Trailing)‪19.60%‬Profit Margin
- NOTXETRNovartis AG259.02BMarket Cap+20.99%52-week change23.66P/E (Trailing)‪22.50%‬Profit Margin
Profile Summary - GIS - Gilead Sciences Inc.
About
Gilead Sciences Inc. is a biopharmaceutical company that discovers, develops, and commercializes medicines addressing unmet medical needs in infectious diseases, oncology, and other therapeutic areas across the United States, Europe, and international markets. Its portfolio centers on HIV treatments, including leading…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
